Leaflet ZOCAP 100mg capsules


Indicated for: epilepsy

Route of administration: oral

Substance: zonisamide (antiepileptic)

ATC: N03AX15 (Nervous system | Antiepileptics | Other antiepileptics)

Precautions:
Driving impairment
Driving impairment

This medicine may affect your ability to drive or use machines.

Dose adjustment in hepatic impairment
Dose adjustment in hepatic impairment

Dose adjustment may be needed in liver disease.

Dose adjustment in renal impairment
Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Suicidal ideation / mental changes
Suicidal ideation / mental changes

Seek medical help if suicidal thoughts or major behavior changes occur.

Drowsiness / sedation
Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Zonisamide is an antiepileptic medication used to treat partial seizures, with or without secondary generalization, in patients with epilepsy. It is also sometimes used as an adjunct therapy for other types of epilepsy. Zonisamide works through multiple mechanisms, including blocking sodium and calcium channels, which reduces neuronal excitability and prevents seizures.

Zonisamide is indicated for both adults and children over the age of 6, typically as an adjunct therapy in cases where other antiepileptic drugs do not provide adequate seizure control. The medication is taken orally, and the dose is gradually adjusted to minimize the risk of side effects.

Common side effects include drowsiness, dizziness, nausea, loss of appetite, and weight loss. Rarely, more serious reactions such as metabolic acidosis, kidney stone formation, or severe allergic reactions may occur. Regular monitoring of kidney function and blood bicarbonate levels is important during treatment.

Zonisamide treatment should be administered under the supervision of a specialist, and patients must strictly follow the prescribed dosage. Abrupt discontinuation of the medication can lead to an increase in seizure frequency, so dose reduction should be done gradually, as directed by the doctor.

General data about ZOCAP 100mg

  • Substance: zonisamide
  • Date of last drug list: 01-06-2026
  • Commercial code: W69803011
  • Concentration: 100mg
  • Pharmaceutical form: capsules
  • Quantity: 98
  • Product type: generic
  • Price: 411.39 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: GLENMARK PHARMACEUTICALS S.R.O. - REPUBLICA CEHA
  • Holder: MAKPHARM D.O.O. - CROATIA
  • Number: 15009/2023/11
  • Shelf life: 3 years

Pharmaceutical forms available for zonisamide

Concentrations available for zonisamide

  • 100mg
  • 20mg/ml
  • 25mg
  • 50mg